Center for Epidemiology and Research in Population health (CERPOP), University of Toulouse, INSERM, UMR1295, 37 allées Jules Guesde, 31000, Toulouse, France.
Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France.
Alzheimers Res Ther. 2021 Sep 24;13(1):157. doi: 10.1186/s13195-021-00904-6.
Preventive interventions for dementia are urgently needed and must be tested in randomised controlled trials (RCTs). Selection (volunteer) bias may limit efficacy, particularly in trials testing multidomain interventions and may also be indicative of disparities in intervention uptake in real-world settings. We identified factors associated with participation and adherence in a 3-year RCT of multidomain lifestyle intervention and/or omega-3 supplementation for prevention of cognitive decline and explored reasons for (non-) participation.
Ancillary study during recruitment and follow-up of the 3-year Multidomain Alzheimer Preventive Trial (MAPT) conducted in in 13 memory centres in France and Monaco, involving 1630 community-dwelling dementia-free individuals aged ≥ 70 who were pre-screened for MAPT (1270 participated in MAPT; 360 declined to participate).
Response rates were 76% amongst MAPT participants and 53% amongst non-participants. Older individuals (odds ratio 0.94 [95% confidence interval 0.91-0.98] and those with higher anxiety (0.61 [0.47-0.79]) were less likely to participate in the trial. Those with higher income (4.42 [2.12-9.19]) and family history (1.60 [1.10-2.32]) or greater fear (1.73 [1.30-2.29]) of dementia were more likely to participate, as were those recruited via an intermediary (e.g. pension funds, local Alzheimer's associations, University of the 3rd Age, sports clubs) (2.15 [1.45-3.20]). MAPT participants living in larger towns (0.71 [0.55-0.92]) and with higher depressive symptoms (0.94 [0.90-0.99]) were less likely to adhere to the interventions. Greater perceived social support (1.21 [1.03-1.43]) and cognitive function (1.37 [1.13-1.67]) predicted better adherence. Descriptively, the most frequent reasons for accepting and refusing to participate were, respectively, altruism and logistical constraints, but underlying motivations mainly related to (lack of) perceived benefits.
Disparities in uptake of health interventions persist in older age. Those most at risk of dementia may not participate in or adhere to preventive interventions. Barriers to implementing lifestyle changes for dementia prevention include lack of knowledge about potential benefits, lack of support networks, and (perceived) financial costs.
NCT00672685 (ClinicalTrials.gov).
迫切需要针对痴呆症的预防干预措施,并且必须在随机对照试验 (RCT) 中进行测试。选择(志愿者)偏倚可能会限制疗效,尤其是在测试多领域干预措施的试验中,并且也可能表明在现实环境中干预措施的接受程度存在差异。我们确定了与一项为期 3 年的多领域生活方式干预和/或欧米伽 3 补充剂预防认知能力下降的 RCT 中参与和依从性相关的因素,并探讨了(不)参与的原因。
在法国和摩纳哥的 13 个记忆中心进行的为期 3 年的多领域阿尔茨海默病预防试验 (MAPT) 的招募和随访期间进行的辅助研究,涉及 1630 名居住在社区、无痴呆的≥70 岁个体,他们预先接受了 MAPT 筛查(1270 名参与者参加了 MAPT;360 名拒绝参加)。
MAPT 参与者的回复率为 76%,非参与者的回复率为 53%。年龄较大的个体(比值比 0.94 [95%置信区间 0.91-0.98])和焦虑程度较高的个体(0.61 [0.47-0.79])不太可能参与试验。收入较高(4.42 [2.12-9.19])和有家族史(1.60 [1.10-2.32])或对痴呆的恐惧程度较高(1.73 [1.30-2.29])的个体更有可能参与,通过中介(例如养老基金、当地阿尔茨海默病协会、大学 3 年级、体育俱乐部)招募的个体也是如此(2.15 [1.45-3.20])。居住在较大城镇的 MAPT 参与者(0.71 [0.55-0.92])和抑郁症状较高的参与者(0.94 [0.90-0.99])不太可能坚持干预措施。更高的感知社会支持(1.21 [1.03-1.43])和认知功能(1.37 [1.13-1.67])预示着更好的依从性。描述性地说,接受和拒绝参与的最常见原因分别是利他主义和后勤限制,但潜在的动机主要与(缺乏)感知到的益处有关。
在老年人中,健康干预措施的接受程度存在差异。那些患痴呆症风险最高的人可能不会参与或坚持预防干预措施。实施痴呆预防生活方式改变的障碍包括对潜在益处缺乏了解、缺乏支持网络和(感知到的)经济成本。
NCT00672685(ClinicalTrials.gov)。